Disparities in influenza treatment among disabled medicaid patients in Georgia

American Journal of Public Health

Volumn 99, Issue SUPPL. 2, 2009, Pages

  Leon, Kyla ^c   McDonald, Marian C ^b   Moore, Barbara ^a   Rust, George ^a  

^a MOREHOUSE SCHOOL OF MEDICINE   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; ANTIVIRUS AGENT; OSELTAMIVIR; ZANAMIVIR;

ADULT; AFRICAN AMERICAN; ANTIVIRAL THERAPY; ARTICLE; COMORBIDITY; DISABLED PERSON; ETHNICITY; EUROPEAN AMERICAN; FEMALE; GEOGRAPHIC DISTRIBUTION; HEALTH DISPARITY; HEALTH PROGRAM; HUMAN; INFLUENZA; MAJOR CLINICAL STUDY; MALE; MEDICAID; RACE; SEX DIFFERENCE; UNITED STATES;

ADOLESCENT; ADULT; AFRICAN AMERICANS; ANTIVIRAL AGENTS; DISABLED PERSONS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GEORGIA; HEALTHCARE DISPARITIES; HUMANS; INFLUENZA, HUMAN; MALE; MEDICAID; MIDDLE AGED; ODDS RATIO; UNITED STATES; YOUNG ADULT;

EID: 70350077051     PISSN: 00900036     EISSN: 15410048     Source Type: Journal    
DOI: 10.2105/AJPH.2008.157602     Document Type: Article

References (38)

1. Oxford JS. Antivirals for the treatment and prevention of epidemic and pandemic influenza. Influenza Other Respi Viruses. 2007;1(1):27-34.
2. Center for Disease Control and Prevention. Seasonal flu. 2008. http://www.cdc.gov/flu. Accessed June 13, 2008.
3. Harper SA, Fukuda K, Uyeki TM, Cox NJ, Bridges CB. Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2005;54(RR-8):1-40.
4. Campbell VA, Sinclair LB, Gilyard JA. Implications of pandemic influenza preparedness and response for people with disabilities. Am J Public Health. In press.
5. US Department of Health and Human Services. Healthy People 2010. Vol.1. Understanding and Improving Health and Objectives for Improving Health. 2nd ed. Washington, DC: US Government Printing Office; November 2000.
6. Aoki FY, Macleod MD, Paggiaro P, et al. Early administration of oral oseltamivir increases the benefits of influenza treatment. J Antimicrob Chemother. 2003;51(1):123-129. (Pubitemid 36163836)
7. Blumenshine P, Reingold A, Egerter S, Mockenhaupt R, Braveman P, Marks J. Pandemic influenza planning in the United States from a health disparities perspective. Emerg Infect Dis. 2008;14(5):709-715. (Pubitemid 351838632)
8. Centers for Disease Control and Prevention. NIS-Adult 2007. Available at: http://www.cdc.gov/VACCINES/stats-surv/nis/downloads/nis-adult-summer-2007.pdf Accessed April 30, 2009.
9. National Health Interview Survey. 2008 Early Release data. Available at: http://www.cdc.gov/nchs/data/nhis/earlyrelease/200809-04.pdf. Accessed October 6, 2008.
10. Schneider EC, Cleary PD, Zaslavsky AM, Epstein AM. Racial disparity in influenza vaccination: does managed care narrow the gap between African Americans and Whites? JAMA. 2001;286(12):1455-1460.
11. Chen JY, Fox SA, Cantrell CH, Stockdale SE, Kagawa-Singer M. Health disparities and prevention: racial/ethnic barriers to flu vaccinations. J Community Health. 2007;32(1):5-20. (Pubitemid 46020956)
12. Smedley BD, Stith AY, Nelson AR, eds. Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care. Committee on Understanding and Eliminating Racial and Ethnic Disparities in Health Care. Washington, DC: National Academies Press; 2002.
13. LaVeist TA. Minority Populations and Health. An Introduction to Health Disparities in the United States. San Francisco, CA: Jossey-Bass; 2005.
14. Livingston IL, ed. Praeger Handbook of Black American Health: Policies and Issues Behind Disparities in Health. Vol.1 and 2. Westport, CT: Praeger; 2004.
15. Geiger HJ. Racial and ethnic disparities in diagnosis and treatment: a review of the evidence and a consideration of cause. In: Smedley BD, Stith AY, Nelson AR, eds. Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care. Committee on Understanding and Eliminating Racial and Ethnic Disparities in Health Care. Washington, DC: National Academies Press; 2002.
16. Rust G, Nembhard WN, Nichols M, et al. Racial and ethnic disparities in the provision of epidural analgesia to Georgia Medicaid beneficiaries during labor and delivery. Am J Obstet Gynecol. 2004;191:456-462. (Pubitemid 39178698)
17. McDonald M, Fultz-Butts KR, et al. Infectious diseases among African Americans. In: Livingston IL, ed. Praeger Handbook of Black American Health: Policies and Issues Behind Disparities in Health. Vol.1 and 2. Westport, CT: Praeger; 2004.
18. Farmer P. Infections and Inequalities: The Modern Plagues. Berkeley: University of California Press; 2001.
19. Daems R, Del Giudice G, Rappuoli R. Anticipating crisis: towards a pandemic flu vaccination strategy through alignment of public health and industrial policy. Vaccine. 2005;23(50):5732-5742. (Pubitemid 41668879)
20. Linder JA, Bates DW, Platt R. Antivirals and antibiotics for influenza in the United States, 1995-2002. Pharmacoepidemiol Drug Saf. 2005;14;531-536. Abstract available at: http://www3.interscience.wiley.com/journal/109865601/ abstract. Accessed November 7, 2008.
21. Gaglia MA Jr, Cook RL, Kraemer KL, Rothberg MB. Patient knowledge and attitudes about antiviral medication and vaccination for influenza in an internal medicine clinic. Clin Infect Dis. 2007;45:1182-1188.
22. Whitley RJ, Monto AS. Seasonal and pandemic influenza preparedness: a global threat. J Infect Dis. 2006;194(suppl 2):S65-S69. (Pubitemid 44630947)
23. Strothers HS 3rd, Rust G, Minor P, Fresh E, Druss B, Satcher D. Disparities in antidepressant treatment in Medicaid elderly diagnosed with depression. J Am Geriatr Soc. 2005;53(3):456-461.
24. Valdez R, Narayan KM, Geiss LS, Engelgau MM. Impact of diabetes mellitus on mortality associated with pneumonia and influenza among non-Hispanic Black and White US adults. Am J Public Health. 1999;89(11):1715-1721. (Pubitemid 29508220)
25. Ingenix. 2007 ICD-9-CM Physicians' Professional: Volumes 1 & 2. Eden Prairie, MN: Ingenix; 2007.
26. US Food and Drug Administration. The National Drug Code Directory. 2008. Available at: http://www.fda.gov/cder/ndc. Accessed June 13, 2008.
27. High levels of adamantane resistance among influenza A (H3N2) viruses and interim guidelines for use of antiviral agents - United States, 2005-06 influenza season. MMWR Morb Mortal Wkly Rep. 2006;55(2):44-46.
28. US Department of Health and Human Services. Area Resource File (ARF) 2004. Rockville, MD: Health Resources and Services Administration, Bureau of Health Professions, US Dept of Health and Human Services; 2004.
29. Gamble VN. Trust, medical care, racial and ethnic minorities. In: Satcher D, Pamies RJ, eds. Multicultural Medicine and Health Disparities. New York, NY: McGraw-Hill Medical Publishing Division; 2006.
30. Howard AR, Ford C, Mclean HM. Disparities in medication use, action, and prescribing for African Americans. In: Livingston IL, ed. Praeger Handbook of Black American Health: Policies and Issues Behind Disparities in Health. Vol.1 and 2. Westport, CT: Praeger; 2004.
31. Keppell KG, Pearcy JN, Klein RJ. Measuring Progress in Healthy People 2010. Atlanta, GA: Centers for Disease Control and Prevention. Available at: http://www.docstoc.com/docs/543087/nchs-data-statnt-statnt-Statistics-and- Public-Health-at-CDC. Accessed February 13, 2009.
32. Rosenbaum S. Racial and ethnic disparities in healthcare: issues in the design, structure, and administration of federal healthcare financing programs supported through direct public funding. In: Smedley BD, Stith AY, Nelson AR, eds. Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care. Committee on Understanding and Eliminating Racial and Ethnic Disparities in Health Care. Washington, DC: National Academies Press; 2002.
33. Cooper LA, Roter DL. Patient-provider communication: the effect of race and ethnicity on process and outcomes of healthcare. In: Smedley BD, Stith AY, Nelson AR, eds. Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care. Committee on Understanding and Eliminating Racial and Ethnic Disparities in Health Care. Washington, DC: National Academies Press; 2002.
34. Nuñez A. Cultural competency. In: Satcher D, Pamies RJ, eds. Multicultural Medicine and Health Disparities. New York, NY: McGraw-Hill Medical Publishing Division; 2006.
35. Good MD, James C, Good BJ, Becker AE. The culture of medicine and racial, ethnic, and class disparities in healthcare. In: Smedley BD, Stith AY, Nelson AR, eds. Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care. Committee on Understanding and Eliminating Racial and Ethnic Disparities in Health Care. Washington, DC: National Academies Press; 2002.
36. Hearne J. CRS Report for Congress: Prescription Drug Coverage Under Medicaid. Table 6. Cost Sharing Requirements for Medicaid Pharmaceuticals as of March 2007. Washington, DC: Congressional Research Service; 2008; page CRS-22.
37. Strom BL. Data validity issues in using claims data. Pharmacoepidemiol Drug Saf. 2001;10:389-392. doi:10.1002/pds.610.
38. Byrd WM, Clayton LA. Racial and ethnic disparities in healthcare: a background and history. In: Smedley BD, Stith AY, Nelson AR, eds. Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care. Committee on Understanding and Eliminating Racial and Ethnic Disparities in Health Care. Washington, DC: National Academies Press; 2002.